首页 | 本学科首页   官方微博 | 高级检索  
     

慢性粒细胞白血病预后因素回顾性队列研究
引用本文:梁晓华,林果为,张文龙. 慢性粒细胞白血病预后因素回顾性队列研究[J]. 中华内科杂志, 2000, 39(12): 835-837
作者姓名:梁晓华  林果为  张文龙
作者单位:上海医科大学华山医院血液科
摘    要:目的 研究影响慢性粒细胞白血病(CML)生存的预后因素。方法 回顾性队列研究158例CML的病例资料,生存曲线用Kaplan-Meier法,预后因素单变量分析用Logrank检验,多变量分析用逐步Cox回归模型。结果 中位生存时间1480d(4年),5年生存率47.1%(95%CI,36.7%~56.9%),10年生存率24.8%(95%CI,15.0%~35.8%)。急变类型以急粒变、急粒单变和

关 键 词:慢性粒细胞白血病 CML 预后 队列研究
修稿时间::

Retrospective cohort study on the prognosis of chronic myeloid leukemia
X Liang,G Lin,W Zhang,Y Shen,Z Tang,W Wu. Retrospective cohort study on the prognosis of chronic myeloid leukemia[J]. Chinese journal of internal medicine, 2000, 39(12): 835-837
Authors:X Liang  G Lin  W Zhang  Y Shen  Z Tang  W Wu
Affiliation:Department of Hematology, Huashan Hospital, Shanghai Medical University, Shanghai 200040, China.
Abstract:OBJECTIVE: To evaluate the prognostic factors of chronic myeloid leukemia (CML). METHODS: Survival curves were plotted according to the Kaplan-Meier method. Variables associated with prognosis were analyzed by Logrank test. A multivariate analysis of prognostic factors was performed using stepwise Cox model. RESULTS: Of the total 158 patients, the median survival time was 1,480 days. 5 years survival rate was 47.1% (95% CI, 36.7% - 56.9%). 10 years was 24.8% (95% CI, 15.0% - 35.8%). The predominant blastic crisis type is myeloblastic, myelomonocytic or monocytic(77.5%). The period from chronic phase to blastic phase was equal in myelosuppressive therapy group, non- myelosuppressive therapy group or altretamine (HMM) group. After evaluated by stepwise Cox's regression model, age>or=50 years, bone marrow blasts>or=0.05, bone marrow basophilic>or=0.05, Ph chromosome negative and HMM treatment were associated with poor prognosis. Hydroxyurea was always associated with longer survival. CONCLUSION: Age, Ph chromosome, bone marrow blasts and basophilic, and various treatment affected the survival of CML.
Keywords:
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号